Transitioning from usual care to biomarker-based personalized and precision medicine in heart failure: call for action (Q53502512)

14 May 2018

title

Transitioning from usual care to biomarker-based personalized and precision medicine in heart failure: call for action. (English)

1 reference

14 May 2018

0 references

0 references

1

Antoni Bayes-Genis

1 reference

14 May 2018

Faiez Zannad

series ordinal

3

object named as

Faiez Zannad

1 reference

14 May 2018

4

James L Januzzi

1 reference

14 May 2018

5

A Mark Richards

1 reference

14 May 2018

Adriaan A Voors

series ordinal

2

object named as

Adriaan A Voors

1 reference

14 May 2018

author name string

Javier Díez

series ordinal

6

1 reference

14 May 2018

publication date

15 February 2017

1 reference

14 May 2018

published in

European Heart Journal

1 reference

14 May 2018

Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX027

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribut

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX027

Clinical epidemiology of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX027

Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX027

EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX027

Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are useful in heart failure management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX027

Development of a novel heart failure risk tool: the barcelona bio-heart failure risk calculator (BCN bio-HF calculator).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX027

Biomarker-assist score for reverse remodeling prediction in heart failure: The ST2-R2 score.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX027

Prediction of survival and magnitude of reverse remodeling using the ST2-R2 score in heart failure: A multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX027

Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX027

Using ST2 in cardiovascular patients: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX027

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX027

Multiple biomarker strategies for risk stratification in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX027

Insulin-Like Growth Factor-Binding Protein-7 as a Biomarker of Diastolic Dysfunction and Functional Capacity in Heart Failure With Preserved Ejection Fraction: Results From the RELAX Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX027

Measurement of novel biomarkers to predict chronic heart failure outcomes and left ventricular remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX027

Prevalence and predictors of heart failure with preserved systolic function: community hospital admissions of a racially and gender diverse elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX027

Circulating biomarkers of collagen metabolism in cardiac diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX027

Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX027

Myocardial Collagen Cross-Linking Is Associated With Heart Failure Hospitalization in Patients With Hypertensive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX027

A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX027

Long Noncoding RNAs in Cardiovascular Pathology, Diagnosis, and Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX027

Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX027

Opportunities for the Cardiovascular Community in the Precision Medicine Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHX027

21 January 2018

Identifiers

DOI

10.1093/EURHEARTJ/EHX027

1 reference

14 May 2018

1 reference

14 May 2018